首页 / 专利分类库 / 有机化学 / 无环或碳环化合物 / 含有羧基的化合物,羧基的双键氧原子被双键氮原子取代,该氮原子不再连接氧原子,例如,亚氨醚、脒
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
141 POLYMERIC ACETOACETANILIDE AZO COLORANTS EP01984933.0 2001-11-26 EP1337509A4 2004-05-19 XIA, Jusong; MASON, Mary, G.; MILEY, John, W.; STEPHENS, Eric, B.; STARKS, Leonard, J.; STEPHENSON, Kyle, E.
This invention related to colorans comprising a chromophore having a single azo acetoacetanilide moiety, wherein said moiety each have at least one poly(oxyalkylene) chain. Such colorants exhibit extremely good base stability and lighfastness, particularly when incorporate within certain media and/or on the surface of certain substrates. These poly(oxyalkylene) chains provide sulubility in different solvents or resins thereby permitting the introduction of such excellent coloring chromophores within diverse media and/or or diverse substrates. Compositions and articles comprising such colorants are provided as are methods for producing such inventive colorants.
142 COMPOSITIONS AND METHODS FOR ENHANCING DRUG DELIVERY ACROSS AND INTO EPITHELIAL TISSUES EP02731103.4 2002-02-25 EP1367995A1 2003-12-10 ROTHBARD, Jonathan, B.; WENDER, Paul, A.; MCGRANE, P., Leo; SISTA, Lalitha, V., S.; KIRSCHBERG, Thorsten, A.
This invention provides compositions and methods for enhancing delivery of drugs and other agents across epithelial tissues, including the skin, gastrointestinal tract, pulmonary epithelium, and the like. The compositions and methods are also useful for delivery across endothelial tissues, including the blood brain barrier. The compositions and methods employ a delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue, compared to the non-conjugated compound. The delivery-enhancing polymers include, for example, poly-arginine molecules that are preferably between about 6 and 25 residues in length (see Figure 44).
143 POLYMERIC ACETOACETANILIDE AZO COLORANTS EP01984933.0 2001-11-26 EP1337509A1 2003-08-27 XIA, Jusong; MASON, Mary, G.; MILEY, John, W.; STEPHENS, Eric, B.; STARKS, Leonard, J.; STEPHENSON, Kyle, E.
This invention related to colorans comprising a chromophore having a single azo acetoacetanilide moiety, wherein said moiety each have at least one poly(oxyalkylene) chain. Such colorants exhibit extremely good base stability and lighfastness, particularly when incorporate within certain media and/or on the surface of certain substrates. These poly(oxyalkylene) chains provide sulubility in different solvents or resins thereby permitting the introduction of such excellent coloring chromophores within diverse media and/or or diverse substrates. Compositions and articles comprising such colorants are provided as are methods for producing such inventive colorants.
144 A soil-disease-controlling agent EP84303640.1 1984-05-30 EP0128006B1 1991-09-18 Tomioka, Hiroki; Ooishi, Tadashi; Takahashi, Junya; Sasaki, Mitsuru; Hirata, Naonori
145 Delta-hydroxy-beta-lysine derivatives and their production EP87118314.1 1987-12-10 EP0271829A3 1989-07-26 Masuya, Hiromoto 1-19 Matsuodai 4-chome; Harada, Setsuo 3-31 Seiwadainishi 2-chome; Natsugari, Hideaki 11-601

compound of the formula wherein R' and R4 are independently amino or an organic residue bonded through nitrogen, R2 is hydrogen or alkyl which may be substituted, R3 is hydrogen or a protecting group and R5 is hydroxyl which may be substituted or amino which may be substituted or salts thereof; with the proviso that when R1 is amino, sorbylamino or hexanoylamino, R2 is hydrogen or methyl, R4 is amino which may be protected adn R5 is hydroxyl or 2-amidinoethylamino, R3 is a protecting group, and that when R1 is amino, leucylamino, acetylamino or benzyloxycarbonylamino, R3 is hydrogen, methyl or 2-tettrahydropyranyl, R4 is amino, acetylamino or benzyloxycarbonylamino and R5 is hydroxyl which may be substituted or amino which may be substituted, R2 is alkyl which may be substituted, has antibacterial activities against drug-resistant bacteria and therefore can be useful as a chemotherapeutic drug for bacterial infections in mammals.

146 Delta-hydroxy-beta-lysine derivatives and their production EP87118314.1 1987-12-10 EP0271829A2 1988-06-22 Masuya, Hiromoto 1-19 Matsuodai 4-chome; Harada, Setsuo 3-31 Seiwadainishi 2-chome; Natsugari, Hideaki 11-601

compound of the formula wherein R' and R4 are independently amino or an organic residue bonded through nitrogen, R2 is hydrogen or alkyl which may be substituted, R3 is hydrogen or a protecting group and R5 is hydroxyl which may be substituted or amino which may be substituted or salts thereof; with the proviso that when R1 is amino, sorbylamino or hexanoylamino, R2 is hydrogen or methyl, R4 is amino which may be protected adn R5 is hydroxyl or 2-amidinoethylamino, R3 is a protecting group, and that when R1 is amino, leucylamino, acetylamino or benzyloxycarbonylamino, R3 is hydrogen, methyl or 2-tettrahydropyranyl, R4 is amino, acetylamino or benzyloxycarbonylamino and R5 is hydroxyl which may be substituted or amino which may be substituted, R2 is alkyl which may be substituted, has antibacterial activities against drug-resistant bacteria and therefore can be useful as a chemotherapeutic drug for bacterial infections in mammals.

147 A soil-disease-controlling agent EP84303640.1 1984-05-30 EP0128006A2 1984-12-12 Tomioka, Hiroki; Ooishi, Tadashi; Takahashi, Junya; Sasaki, Mitsuru; Hirata, Naonori

A soil disease controlling agent for preventing and controlling diseases caused by pathogenic fungi living in soil, which comprises an effective amount of at least one of a 2-cycloalkenylamine derivative and its salts as an active ingredient, and at least one inert carrier or diluent.

148 INOSITOL AND TREHALOSE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES COMPRISING THE SAME EP09800493.0 2009-03-23 EP2321265A1 2011-05-18 CHUNG, Sung-Kee; LEE, Woo Sirl; KIM, Boram; IM, Jungkyun; SUBHASH, C. Ghosh
The invented inositol and trehalose derivatives, prepared by introducing multiple units of the guanidine group to the backbone molecules, show excellent blood-brain barrier permeability, and accordingly, it can be easily transported to the brain tissues and utilized for the treatment of neurodegenerative diseases such as Alzheimer¡s disease and Huntington's disease.
149 NOVEL AMIDINE COMPOUNDS FOR TREATING MICROBIAL INFECTIONS EP03818831.4 2003-09-05 EP1663959A4 2007-10-31 TIDWELL, Richard R.; BOYKIN, David; BRUN, Reto; STEPHENS, Chad, E.; KUMAR, Arvind
Novel amidine and diamidine compounds are useful in the treatment of microbial infections, including mycobacterial, fungal and protozoal infections. Pharmaceutical formulations comprising these compounds can be used in methods of treating microbial infections.
150 HEPARANASE INHIBITORS AND USES THEREOF EP05703192.4 2005-02-06 EP1720828A2 2006-11-15 VAN GELDER, Joel M.; BASEL, Yochai; KRAIZ, Boris O.; MOUALLEM, Orly; MIRON, Daphna; GUR-ARIE, Nina; KLEIN, Joseph
The invention provides heparanase inhibitors suitable for treatment of diseases and disorders caused by or associated with heparanase catalytic activity such as cancer, inflammatory disorders and autoimmune diseases.
151 NOVEL AMIDINE COMPOUNDS FOR TREATING MICROBIAL INFECTIONS EP03818831.4 2003-09-05 EP1663959A1 2006-06-07 TIDWELL, Richard R.; BOYKIN, David; BRUN, Reto; STEPHENS, Chad, E.; KUMAR, Arvind
Novel amidine and diamidine compounds are useful in the treatment of microbial infections, including mycobacterial, fungal and protozoal infections. Pharmaceutical formulations comprising these compounds can be used in methods of treating microbial infections.
152 NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS EP96944123.7 1996-12-05 EP0865281B1 2002-04-03 ARNAIZ, Damian, O.; GRIEDEL, Brian, D.; SAKATA, Stephen, T.; SHAW, Kenneth, J.; ZHAO, Zuchan
Novel naphthyl-substituted benzimidazole compounds and their pharmaceutically acceptable salts are described herein. This invention is also directed to an anticoagulant composition comprising a naphthyl-substituted benzimidazole compound described herein. The novel compound or its composition has inhibitory activity against human factor Xa or IIa, thereby useful in treating a disease state mediated by factor Xa or IIa.
153 Plant growth regulating composition EP90112585.6 1990-07-02 EP0406760B1 1994-10-05 Izumi, Kazuo; Katoh, Tsuguhiro; Muranaka, Toshiya; Sanemitsu, Yuzuru
154 Delta-hydroxy-beta-lysine derivatives and their production EP87118314.1 1987-12-10 EP0271829B1 1993-08-25 Masuya, Hiromoto 1-19 Matsuodai 4-chome; Harada, Setsuo 3-31 Seiwadainishi 2-chome; Natsugari, Hideaki 11-601
155 N-phenylalkylbenzamide fungicides EP88309998.8 1988-10-25 EP0314422B1 1993-07-28 Arnold, Wendell Ray; Davenport, James David
156 Diphenyl-methane derivative, pharmaceutical composition and use EP87103834.5 1987-03-17 EP0238973B1 1992-12-02 Yamagishi, Youji; Akasaka, Kozo; Suzuki, Takeshi; Miyamoto, Mitsuaki; Nakamoto, Kouji; Okano, Kazuo; Abe, Shinya; Ikuta, Hironori; Hayashi, Kenji; Yoshimura, Hiroyuki; Fujimori, Tohru; Harada, Koukichi; Yamatsu, Isao
157 Plant growth regulating composition EP90112585.6 1990-07-02 EP0406760A1 1991-01-09 Izumi, Kazuo; Katoh, Tsuguhiro; Muranaka, Toshiya; Sanemitsu, Yuzuru

A plant growth regulating composition comprising as the active ingredient an amidinoformic acid derivative of the formula: wherein R₁ is a hydrogen atom, a C₁-C₃ alkyl group, a C₁-C₃ alkoxy group, a C₁-C₃ alkylthio group or a halogen atom, R₂s are, the same or different, each a C₁-C₃ alkyl group or a halogen atom, R₃ is a hydroxy group, a C₁-C₅ alkoxy group, a benzyloxy group or a di(C₁-C₃)alkylamino group and n is an integer of 0, 1 or 2, or its salt, and an inert carrier or diluent.

158 Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia EP88310395.4 1988-11-04 EP0315467A3 1990-09-26 Pai, Sadanand; Alam, Abu S.; Kapoor, John N.

Salts of pentamidine, formulations containing such salts and the use of such salts for treatment or prophylaxis of pneumocystis carinii. Pentamidine gluconate and lactate has been discovered and found to have high water solubility while providing potentially less toxic alternatives to pentamidine isethionate, especially for aerosolized administration to patients suffering from acquired immunodeficiency syndrome, AIDS, or AIDS related complex, ARC.

159 Phenylalanine derivative and proteinase inhibitor EP86113166.2 1986-09-24 EP0217286B1 1990-05-23 Okamoto, Shosuke; Okada, Yoshio; Okunomiya, Akiko; Naito, Taketoshi SHOWA DENKO K.K.; Kimura, Yoshio SHOWA DENKO K.K.; Yamada, Morihiko SHOWA DENKO K.K.; Ohno, Norio SHOWA DENKO K.K.; Katsuura, Yasuhiro SHOWA DENKO K.K.; Seki, Yumi SHOWA DENKO K.K.
160 Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia EP88310395.4 1988-11-04 EP0315467A2 1989-05-10 Pai, Sadanand; Alam, Abu S.; Kapoor, John N.

Salts of pentamidine, formulations containing such salts and the use of such salts for treatment or prophylaxis of pneumocystis carinii. Pentamidine gluconate and lactate has been discovered and found to have high water solubility while providing potentially less toxic alternatives to pentamidine isethionate, especially for aerosolized administration to patients suffering from acquired immunodeficiency syndrome, AIDS, or AIDS related complex, ARC.

QQ群二维码
意见反馈